That's because it is like the boy that cried wolf. We keep seeing press release after press release with potentially valuable associations with their tests. But quarter after quarter, growth is at a trickle. Nobody believes until it starts showing up on the bottom line, which so far it hasn't. We see more momentum with rumors of a buyout than anything to do with their actual products.